世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000036886

再生医療の世界市場(2024-2028)

TechNavio

Global Regenerative Medicine Market 2024-2028

発刊日 2023/10/17

言語英語

体裁PDF/178ページ

ライセンス/価格178ページ

0000036886

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

再生医療市場は2023年から2028年に701億1,007万米ドル、予測期間中のCAGRは23.31%で成長すると予測されています。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。慢性疾患の増加、公的・民間ヘルスケア機関からの支援の増加、幹細胞治療の採用増加などが市場を牽引しています。

調査範囲

  • 市場セグメント
    ➣ 用途別
      ◇ 腫瘍学
      ◇ 筋骨格系
      ◇ 皮膚科
      ◇ 免疫学、炎症学など
    ➣ 技術別
      ◇ 細胞
      ◇ 組織ベース
      ◇ 遺伝子治療
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ 世界のその他の地域(ROW)

本調査では、今後数年間の再生医療市場成長を牽引する主な要因の一つとして、臨床試験数の増加を挙げています。また、世界の再生医療市場における新たな技術的進歩やキメラ抗原受容体T細胞(CAR-T)療法の注目度の高まりは、同市場における大きな需要につながります。

再生医療市場に関するレポートは、次の分野をカバーしています。

  • 再生医療市場の規模
  • 再生医療市場の予測
  • 再生医療市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。

  • 調査企業
    ➣ AbbVie Inc.
    ➣ Amgen Inc.
    ➣ Baxter International Inc.
    ➣ Becton Dickinson and Co.
    ➣ Cook Group Inc.
    ➣ F. Hoffmann La Roche Ltd.
    ➣ Gilead Sciences Inc.
    ➣ Integra Lifesciences Corp.
    ➣ Johnson and Johnson
    ➣ Medtronic Plc
    ➣ Merck and Co. Inc.
    ➣ Mesoblast Ltd.
    ➣ MiMedx Group Inc.
    ➣ Novartis AG
    ➣ Nuvasive Inc.
    ➣ Organogenesis Holdings Inc.
    ➣ Smith and Nephew plc
    ➣ Thermo Fisher Scientific Inc.
    ➣ Vericel Corp.
    ➣ Zimmer Biomet Holdings Inc.

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by Technology
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global regenerative medicine market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global regenerative medicine market 2018 - 2022 ($ million)
4.2 Application Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.3 Technology Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Technology Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application
6.1 Market segments
Exhibit 30: Chart on Application - Market share 2023-2028 (%)
Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Oncology - Market size and forecast 2023-2028
Exhibit 34: Chart on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Oncology - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Oncology - Year-over-year growth 2023-2028 (%)
6.4 Musculoskeletal - Market size and forecast 2023-2028
Exhibit 38: Chart on Musculoskeletal - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Musculoskeletal - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Musculoskeletal - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Musculoskeletal - Year-over-year growth 2023-2028 (%)
6.5 Dermatology - Market size and forecast 2023-2028
Exhibit 42: Chart on Dermatology - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Dermatology - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Dermatology - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Dermatology - Year-over-year growth 2023-2028 (%)
6.6 Immunology and inflammation and others - Market size and forecast 2023-2028
Exhibit 46: Chart on Immunology and inflammation and others - Market size and forecast 2023-2028 ($ million)
Exhibit 47: Data Table on Immunology and inflammation and others - Market size and forecast 2023-2028 ($ million)
Exhibit 48: Chart on Immunology and inflammation and others - Year-over-year growth 2023-2028 (%)
Exhibit 49: Data Table on Immunology and inflammation and others - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Application
Exhibit 50: Market opportunity by Application ($ million)
Exhibit 51: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Technology
7.1 Market segments
Exhibit 52: Chart on Technology - Market share 2023-2028 (%)
Exhibit 53: Data Table on Technology - Market share 2023-2028 (%)
7.2 Comparison by Technology
Exhibit 54: Chart on Comparison by Technology
Exhibit 55: Data Table on Comparison by Technology
7.3 Cell and tissue-based - Market size and forecast 2023-2028
Exhibit 56: Chart on Cell and tissue-based - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Cell and tissue-based - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Cell and tissue-based - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Cell and tissue-based - Year-over-year growth 2023-2028 (%)
7.4 Gene therapy - Market size and forecast 2023-2028
Exhibit 60: Chart on Gene therapy - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Data Table on Gene therapy - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Chart on Gene therapy - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Gene therapy - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Technology
Exhibit 64: Market opportunity by Technology ($ million)
Exhibit 65: Data Table on Market opportunity by Technology ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 Japan - Market size and forecast 2023-2028
Exhibit 95: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Exhibit 103: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 104: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 105: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ million)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 115: AbbVie Inc. - Overview
Exhibit 116: AbbVie Inc. - Product / Service
Exhibit 117: AbbVie Inc. - Key news
Exhibit 118: AbbVie Inc. - Key offerings
12.4 Amgen Inc.
Exhibit 119: Amgen Inc. - Overview
Exhibit 120: Amgen Inc. - Product / Service
Exhibit 121: Amgen Inc. - Key offerings
12.5 Baxter International Inc.
Exhibit 122: Baxter International Inc. - Overview
Exhibit 123: Baxter International Inc. - Business segments
Exhibit 124: Baxter International Inc. - Key news
Exhibit 125: Baxter International Inc. - Key offerings
Exhibit 126: Baxter International Inc. - Segment focus
12.6 Becton Dickinson and Co.
Exhibit 127: Becton Dickinson and Co. - Overview
Exhibit 128: Becton Dickinson and Co. - Business segments
Exhibit 129: Becton Dickinson and Co. - Key news
Exhibit 130: Becton Dickinson and Co. - Key offerings
Exhibit 131: Becton Dickinson and Co. - Segment focus
12.7 Cook Group Inc.
Exhibit 132: Cook Group Inc. - Overview
Exhibit 133: Cook Group Inc. - Product / Service
Exhibit 134: Cook Group Inc. - Key offerings
12.8 Integra Lifesciences Corp.
Exhibit 135: Integra Lifesciences Corp. - Overview
Exhibit 136: Integra Lifesciences Corp. - Business segments
Exhibit 137: Integra Lifesciences Corp. - Key news
Exhibit 138: Integra Lifesciences Corp. - Key offerings
Exhibit 139: Integra Lifesciences Corp. - Segment focus
12.9 Medtronic Plc
Exhibit 140: Medtronic Plc - Overview
Exhibit 141: Medtronic Plc - Business segments
Exhibit 142: Medtronic Plc - Key news
Exhibit 143: Medtronic Plc - Key offerings
Exhibit 144: Medtronic Plc - Segment focus
12.10 Merck and Co. Inc.
Exhibit 145: Merck and Co. Inc. - Overview
Exhibit 146: Merck and Co. Inc. - Business segments
Exhibit 147: Merck and Co. Inc. - Key news
Exhibit 148: Merck and Co. Inc. - Key offerings
Exhibit 149: Merck and Co. Inc. - Segment focus
12.11 MiMedx Group Inc.
Exhibit 150: MiMedx Group Inc. - Overview
Exhibit 151: MiMedx Group Inc. - Business segments
Exhibit 152: MiMedx Group Inc. - Key news
Exhibit 153: MiMedx Group Inc. - Key offerings
Exhibit 154: MiMedx Group Inc. - Segment focus
12.12 Novartis AG
Exhibit 155: Novartis AG - Overview
Exhibit 156: Novartis AG - Business segments
Exhibit 157: Novartis AG - Key offerings
Exhibit 158: Novartis AG - Segment focus
12.13 Nuvasive Inc.
Exhibit 159: Nuvasive Inc. - Overview
Exhibit 160: Nuvasive Inc. - Business segments
Exhibit 161: Nuvasive Inc. - Key news
Exhibit 162: Nuvasive Inc. - Key offerings
Exhibit 163: Nuvasive Inc. - Segment focus
12.14 Organogenesis Holdings Inc.
Exhibit 164: Organogenesis Holdings Inc. - Overview
Exhibit 165: Organogenesis Holdings Inc. - Product / Service
Exhibit 166: Organogenesis Holdings Inc. - Key offerings
12.15 Smith and Nephew plc
Exhibit 167: Smith and Nephew plc - Overview
Exhibit 168: Smith and Nephew plc - Business segments
Exhibit 169: Smith and Nephew plc - Key news
Exhibit 170: Smith and Nephew plc - Key offerings
Exhibit 171: Smith and Nephew plc - Segment focus
12.16 Thermo Fisher Scientific Inc.
Exhibit 172: Thermo Fisher Scientific Inc. - Overview
Exhibit 173: Thermo Fisher Scientific Inc. - Business segments
Exhibit 174: Thermo Fisher Scientific Inc. - Key news
Exhibit 175: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 176: Thermo Fisher Scientific Inc. - Segment focus
12.17 Vericel Corp.
Exhibit 177: Vericel Corp. - Overview
Exhibit 178: Vericel Corp. - Product / Service
Exhibit 179: Vericel Corp. - Key news
Exhibit 180: Vericel Corp. - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 181: Inclusions checklist
Exhibit 182: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 183: Currency conversion rates for US$
13.4 Research methodology
Exhibit 184: Research methodology
Exhibit 185: Validation techniques employed for market sizing
Exhibit 186: Information sources
13.5 List of abbreviations
Exhibit 187: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by Technology
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global regenerative medicine market 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Technology Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Application - Market share 2023-2028 (%)
Exhibits31: Data Table on Application - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Oncology - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Oncology - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Musculoskeletal - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Musculoskeletal - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Musculoskeletal - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Musculoskeletal - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Dermatology - Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Dermatology - Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Dermatology - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Dermatology - Year-over-year growth 2023-2028 (%)
Exhibits46: Chart on Immunology and inflammation and others - Market size and forecast 2023-2028 ($ million)
Exhibits47: Data Table on Immunology and inflammation and others - Market size and forecast 2023-2028 ($ million)
Exhibits48: Chart on Immunology and inflammation and others - Year-over-year growth 2023-2028 (%)
Exhibits49: Data Table on Immunology and inflammation and others - Year-over-year growth 2023-2028 (%)
Exhibits50: Market opportunity by Application ($ million)
Exhibits51: Data Table on Market opportunity by Application ($ million)
Exhibits52: Chart on Technology - Market share 2023-2028 (%)
Exhibits53: Data Table on Technology - Market share 2023-2028 (%)
Exhibits54: Chart on Comparison by Technology
Exhibits55: Data Table on Comparison by Technology
Exhibits56: Chart on Cell and tissue-based - Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Cell and tissue-based - Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Cell and tissue-based - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Cell and tissue-based - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Gene therapy - Market size and forecast 2023-2028 ($ million)
Exhibits61: Data Table on Gene therapy - Market size and forecast 2023-2028 ($ million)
Exhibits62: Chart on Gene therapy - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Gene therapy - Year-over-year growth 2023-2028 (%)
Exhibits64: Market opportunity by Technology ($ million)
Exhibits65: Data Table on Market opportunity by Technology ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits104: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits105: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2023 and 2028
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: AbbVie Inc. - Overview
Exhibits116: AbbVie Inc. - Product / Service
Exhibits117: AbbVie Inc. - Key news
Exhibits118: AbbVie Inc. - Key offerings
Exhibits119: Amgen Inc. - Overview
Exhibits120: Amgen Inc. - Product / Service
Exhibits121: Amgen Inc. - Key offerings
Exhibits122: Baxter International Inc. - Overview
Exhibits123: Baxter International Inc. - Business segments
Exhibits124: Baxter International Inc. - Key news
Exhibits125: Baxter International Inc. - Key offerings
Exhibits126: Baxter International Inc. - Segment focus
Exhibits127: Becton Dickinson and Co. - Overview
Exhibits128: Becton Dickinson and Co. - Business segments
Exhibits129: Becton Dickinson and Co. - Key news
Exhibits130: Becton Dickinson and Co. - Key offerings
Exhibits131: Becton Dickinson and Co. - Segment focus
Exhibits132: Cook Group Inc. - Overview
Exhibits133: Cook Group Inc. - Product / Service
Exhibits134: Cook Group Inc. - Key offerings
Exhibits135: Integra Lifesciences Corp. - Overview
Exhibits136: Integra Lifesciences Corp. - Business segments
Exhibits137: Integra Lifesciences Corp. - Key news
Exhibits138: Integra Lifesciences Corp. - Key offerings
Exhibits139: Integra Lifesciences Corp. - Segment focus
Exhibits140: Medtronic Plc - Overview
Exhibits141: Medtronic Plc - Business segments
Exhibits142: Medtronic Plc - Key news
Exhibits143: Medtronic Plc - Key offerings
Exhibits144: Medtronic Plc - Segment focus
Exhibits145: Merck and Co. Inc. - Overview
Exhibits146: Merck and Co. Inc. - Business segments
Exhibits147: Merck and Co. Inc. - Key news
Exhibits148: Merck and Co. Inc. - Key offerings
Exhibits149: Merck and Co. Inc. - Segment focus
Exhibits150: MiMedx Group Inc. - Overview
Exhibits151: MiMedx Group Inc. - Business segments
Exhibits152: MiMedx Group Inc. - Key news
Exhibits153: MiMedx Group Inc. - Key offerings
Exhibits154: MiMedx Group Inc. - Segment focus
Exhibits155: Novartis AG - Overview
Exhibits156: Novartis AG - Business segments
Exhibits157: Novartis AG - Key offerings
Exhibits158: Novartis AG - Segment focus
Exhibits159: Nuvasive Inc. - Overview
Exhibits160: Nuvasive Inc. - Business segments
Exhibits161: Nuvasive Inc. - Key news
Exhibits162: Nuvasive Inc. - Key offerings
Exhibits163: Nuvasive Inc. - Segment focus
Exhibits164: Organogenesis Holdings Inc. - Overview
Exhibits165: Organogenesis Holdings Inc. - Product / Service
Exhibits166: Organogenesis Holdings Inc. - Key offerings
Exhibits167: Smith and Nephew plc - Overview
Exhibits168: Smith and Nephew plc - Business segments
Exhibits169: Smith and Nephew plc - Key news
Exhibits170: Smith and Nephew plc - Key offerings
Exhibits171: Smith and Nephew plc - Segment focus
Exhibits172: Thermo Fisher Scientific Inc. - Overview
Exhibits173: Thermo Fisher Scientific Inc. - Business segments
Exhibits174: Thermo Fisher Scientific Inc. - Key news
Exhibits175: Thermo Fisher Scientific Inc. - Key offerings
Exhibits176: Thermo Fisher Scientific Inc. - Segment focus
Exhibits177: Vericel Corp. - Overview
Exhibits178: Vericel Corp. - Product / Service
Exhibits179: Vericel Corp. - Key news
Exhibits180: Vericel Corp. - Key offerings
Exhibits181: Inclusions checklist
Exhibits182: Exclusions checklist
Exhibits183: Currency conversion rates for US$
Exhibits184: Research methodology
Exhibits185: Validation techniques employed for market sizing
Exhibits186: Information sources
Exhibits187: List of abbreviations

この商品のレポートナンバー

0000036886

TOP